Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep Learning.
Ryan FogartyDmitry B GoldgofLawrence HallAlex LopezJoseph JohnsonManoj GadaraRadka StoyanovaSanoj PunnenAlan PollackJulio Pow-SangBalagurunathan YogaPublished in: Cancers (2023)
Histopathological classification in prostate cancer remains a challenge with high dependence on the expert practitioner. We develop a deep learning (DL) model to identify the most prominent Gleason pattern in a highly curated data cohort and validate it on an independent dataset. The histology images are partitioned in tiles (14,509) and are curated by an expert to identify individual glandular structures with assigned primary Gleason pattern grades. We use transfer learning and fine-tuning approaches to compare several deep neural network architectures that are trained on a corpus of camera images (ImageNet) and tuned with histology examples to be context appropriate for histopathological discrimination with small samples. In our study, the best DL network is able to discriminate cancer grade (GS3/4) from benign with an accuracy of 91%, F 1 -score of 0.91 and AUC 0.96 in a baseline test (52 patients), while the cancer grade discrimination of the GS3 from GS4 had an accuracy of 68% and AUC of 0.71 (40 patients).
Keyphrases
- deep learning
- prostate cancer
- end stage renal disease
- convolutional neural network
- radical prostatectomy
- ejection fraction
- peritoneal dialysis
- chronic kidney disease
- machine learning
- artificial intelligence
- neural network
- squamous cell carcinoma
- papillary thyroid
- patient reported outcomes
- computed tomography
- prognostic factors
- electronic health record
- big data
- ultrasound guided
- high resolution
- magnetic resonance imaging
- young adults
- magnetic resonance
- squamous cell
- benign prostatic hyperplasia